Anti-Amyloid-β Monoclonal Antibodies against Alzheimer’s disease may be a potential breakthrough for cataract treatment

• DOI: 10.22541/au.167938573.31885613/v1
• Publication Date: 2023-03-21T08:02:24Z
• Authors: Ali Rahmani; Maedeh Dahaghin
• Keywords: Visual Impairment

Cataracts are considered the underlying cause of blindness globally. When average age earth’s population is on rise, cataract-induced and visual dysfunction will increase dramatically. (1) Currently, only viable treatment for cataracts surgery, including removing opaque lens replacing it with an artificial one which has a huge impact improving patient’s quality life. Undoubtedly, have far-reaching repercussions countries in terms social economic burdens, example, increasing rate automobile accidents due to reduced acuity. (2) Nonetheless, lack facilities, ophthalmologists, funds, surgery not choice developing countries. (3) It should be noted that posterior capsular opacification common complication cataracts, sometimes, second intervention necessary. (4)This research thrown up many questions need further investigation find medications restore full transparency lens.